115 related articles for article (PubMed ID: 7681051)
1. Phase I-II study of multiple daily fractions for palliation of advanced head and neck malignancies.
Paris KJ; Spanos WJ; Lindberg RD; Jose B; Albrink F
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):657-60. PubMed ID: 7681051
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: preliminary report of RTOG 8502.
Spanos W; Guse C; Perez C; Grigsby P; Doggett RL; Poulter C
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):659-61. PubMed ID: 2476426
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
4. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme.
Chen AM; Vaughan A; Narayan S; Vijayakumar S
Head Neck; 2008 Dec; 30(12):1586-91. PubMed ID: 18798313
[TBL] [Abstract][Full Text] [Related]
5. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
[TBL] [Abstract][Full Text] [Related]
6. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
7. Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: a preliminary report.
Arias F; Domínguez MA; Illarramendi JJ; Martínez E; Tejedor M; Domínguez S; Dueñas M; Villafranca E; Elcarte F; Miquéliz S
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):675-82. PubMed ID: 7558958
[TBL] [Abstract][Full Text] [Related]
8. Split-course accelerated therapy in head and neck cancer: an analysis of toxicity.
Delaney GP; Fisher RJ; Smee RI; Hook C; Barton MB
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):763-8. PubMed ID: 7790263
[TBL] [Abstract][Full Text] [Related]
9. Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck.
MacKenzie R; Balogh J; Choo R; Franssen E
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):589-95. PubMed ID: 10524410
[TBL] [Abstract][Full Text] [Related]
10. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
12. Phase I-II Study of Short-course Accelerated Radiotherapy (SHARON) for Palliation in Head and Neck Cancer.
Farina E; Capuccini J; Macchia G; Caravatta L; Nguyen NP; Cammelli S; Farioli A; Zanirato Rambaldi G; Cilla S; Wondemagegnhu T; Uddin AFMK; Sumon MA; Genovesi D; Buwenge M; Cellini F; Valentini V; Deodato F; Morganti AG
Anticancer Res; 2018 Apr; 38(4):2409-2414. PubMed ID: 29599369
[TBL] [Abstract][Full Text] [Related]
13. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
[TBL] [Abstract][Full Text] [Related]
14. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
[TBL] [Abstract][Full Text] [Related]
15. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
Herchenhorn D; Dias FL; Viegas CM; Federico MH; Araújo CM; Small I; Bezerra M; Fontão K; Knust RE; Ferreira CG; Martins RG
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):696-702. PubMed ID: 20421154
[TBL] [Abstract][Full Text] [Related]
17. End stage palliative care of head and neck cancer: a case study.
Shishodia NP; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Pathan AA; Parine NR; Chandroth SV; Purushothaman B
Asian Pac J Cancer Prev; 2015; 16(3):1255-8. PubMed ID: 25735365
[TBL] [Abstract][Full Text] [Related]
18. Late effect of multiple daily fraction palliation schedule for advanced pelvic malignancies (RTOG 8502).
Spanos WJ; Clery M; Perez CA; Grigsby PW; Doggett RL; Poulter CA; Steinfeld AD
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):961-7. PubMed ID: 8083097
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
20. Palliation of pelvic and head and neck cancer with paclitaxel and a novel radiotherapy regimen.
Carrascosa LA; Yashar CM; Paris KJ; Larocca RV; Faught SR; Spanos WJ
J Palliat Med; 2007 Aug; 10(4):877-81. PubMed ID: 17803408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
